KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Weighted Average and Diluted): 2015-2024

Historic EPS (Weighted Average and Diluted) for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $12.63.

  • Medpace Holdings' EPS (Weighted Average and Diluted) rose 28.24% to $3.86 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.30, marking a year-over-year increase of 25.22%. This contributed to the annual value of $12.63 for FY2024, which is 42.23% up from last year.
  • As of FY2024, Medpace Holdings' EPS (Weighted Average and Diluted) stood at $12.63, which was up 42.23% from $8.88 recorded in FY2023.
  • In the past 5 years, Medpace Holdings' EPS (Weighted Average and Diluted) registered a high of $12.63 during FY2024, and its lowest value of $3.84 during FY2020.
  • For the 3-year period, Medpace Holdings' EPS (Weighted Average and Diluted) averaged around $9.60, with its median value being $8.88 (2023).
  • Data for Medpace Holdings' EPS (Weighted Average and Diluted) shows a peak YoY spiked of 51.35% (in 2022) over the last 5 years.
  • Over the past 5 years, Medpace Holdings' EPS (Weighted Average and Diluted) (Yearly) stood at $3.84 in 2020, then climbed by 25.26% to $4.81 in 2021, then spiked by 51.35% to $7.28 in 2022, then rose by 21.98% to $8.88 in 2023, then skyrocketed by 42.23% to $12.63 in 2024.